Corvus Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Corvus Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Corvus Pharmaceuticals Inc
Access all reports
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies for the treatment of cancers. It develops COR 09012, a patient-specific CAR T cell therapy for the potential treatment of hematologic malignancies and solid tumors. The company was incorporated in 2014 and is based in Burlingame, California.
Key slides for Corvus Pharmaceuticals Inc
Corporate Presentation
Corvus Pharmaceuticals Inc
Corporate Presentation
Corvus Pharmaceuticals Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States